Significance of thyroid blood flow as a predictor of methimazole sensitivity in untreated hyperthyroid patients with Graves' disease

Biomedicine and Pharmacotherapy

Volumn 61, Issue 8, 2007, Pages 472-476

  Nagasaki, Toshiki ^a   Inaba, Masaaki ^a   Kumeda, Yasuro ^a   Fujiwara Ueda, Misako ^a   Hiura, Yoshikazu ^a   Nishizawa, Yoshiki ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Color Doppler measurement; Graves' disease; Hyperthyroidism; Immunoglobulin E; Inferior thyroid artery; Methimazole

Indexed keywords

AUTOANTIBODY; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IMMUNOGLOBULIN E; LIOTHYRONINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THIAMAZOLE; THYROTROPIN; THYROTROPIN ANTIBODY; THYROTROPIN RECEPTOR ANTIBODY; THYROXINE; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADOLESCENT; ADULT; AGED; APPARATUS; ARTERY; ARTICLE; BLOOD FLOW VELOCITY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOPPLER FLOWMETRY; DRUG DOSE TITRATION; DRUG SENSITIVITY; FEMALE; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; IMAGE ANALYSIS; IMMUNOGLOBULIN BLOOD LEVEL; INFERIOR THYROID ARTERY; MAINTENANCE DRUG DOSE; MALE; ORGAN BLOOD FLOW; PREDICTION; PRIORITY JOURNAL; REGRESSION ANALYSIS; SMOKING; SYSTOLE;

ADOLESCENT; ADULT; AGED; ANTITHYROID AGENTS; BLOOD FLOW VELOCITY; FEMALE; GRAVES DISEASE; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULINS, THYROID-STIMULATING; MALE; METHIMAZOLE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RECEPTORS, THYROTROPIN; REGIONAL BLOOD FLOW; THYROID GLAND; THYROXINE; TRIIODOTHYRONINE; ULTRASONOGRAPHY, DOPPLER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 34548524177     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2007.02.002     Document Type: Article

References (16)

1. Bogazzi F., Bartalena L., Brogioni S., Burelli A., Manetti L., Tanda M.L., et al. Thyroid vascularity and blood flow are not dependent on serum thyroid hormone levels: studies in vivo by color flow Doppler sonography. European Journal of Endocrinology 140 (1999) 452
2. Ueda M., Inaba M., Kumeda Y., Nagasaki T., Hiura Y., Tahara H., et al. The significance of thyroid blood flow at the inferior thyroid artery as a predictor for early Graves' diseases relapse. Clinical Endocrinology 63 (2005) 657
3. Sato A., Takemura Y., Yamada T., Ohtsuka H., Sakai H., Miyahara Y., et al. A possible role of immunoglobulin E in patients with hyperthyroid Graves' disease. The Journal of Clinical Endocrinology and Metabolism 84 (1999) 3602
4. Yamada T., Sato A., Komiya I., Nishimori T., Ito Y., Terao A., et al. An elevation of serum immunoglobulin E provides a new aspect of hyperthyroid Graves' disease. The Journal of Clinical Endocrinology and Metabolism 85 (2000) 2775
5. Komiya I., Yamada T., Sato A., Kouki T., Nishimori T., and Takasu N. Remission and recurrence of hyperthyroid Graves' disease during and after methimazole treatment when assessed by IgE and interleukin 13. The Journal of Clinical Endocrinology and Metabolism 86 (2001) 3540
6. Christofides N.D., and Sheehan C.P. Enhanced chemiluminescence labeled-antibody immunoassay (Amerlite-MAB) for free thyroxine: design, development, and technical validation. Clinical Chemistry 41 (1995) 17
7. Smith B.R., and Hall R. Thyroid-stimulating immunoglobulins in Graves' disease. Lancet 2 (1974) 427
8. Yoshikawa N., Nishikawa M., Horimoto M., Uno C., Taniguchi N., and Inada M. Activity of thyroid stimulating antibody and thyroid stimulation blocking antibody determined by radioiodine uptake into FRTL-5 cells. Endocrinologia Japonica 36 (1989) 55
9. Paganelli R., Ansotegui I.J., Sastre J., Lange C.E., Roovers M.H., de Groot H., et al. Specific IgE antibodies in the diagnosis of atopic disease. Clinical evaluation of a new in vitro test system, UniCAP, in six European allergy clinics. Allergy 53 (1998) 763
10. Cooper B.C., Ritchie J.M., Broghammer C.L., Coffin J., Sorosky J.I., Buller R.E., et al. Preoperative serum vascular endothelial growth factor levels: significance in ovarian cancer. Clinical Cancer Research 8 (2002) 3193
11. Lacy M.J., Wang R., Brookshire V., and Floyd K. Adaptation of commercial immunoassays to analysis of complex biological substances. Journal of Immunoassay and Immunochemistry 23 (2002) 1
12. Murakami Y., Takamatsu J., Sakane S., Kuma K., and Ohsawa N. Changes in thyroid volume in response to radioactive iodine for Graves' hyperthyroidism correlated with activity of thyroid-stimulating antibody and treatment outcome. The Journal of Clinical Endocrinology and Metabolism 81 (1996) 3257
13. Kung A.W., Pang R.W., Lauder I., Lam K.S., and Janus E.D. Changes in serum lipoprotein (a) and lipids during treatment of hyperthyroidism. Clinical Chemistry 41 (1995) 226
14. Holm I.A., Manson J.E., Michels K.B., Alexander E.K., Willett W.C., and Utiger R.D. Smoking and other lifestyle factors and the risk of Graves' hyperthyroidism. Archives of internal medicine 165 (2005) 1606
15. Massart C., Orgiazzi J., and Maugendre D. Clinical validity of a new commercial method for detection of TSH-receptor binding antibodies in sera from patients with Graves' disease treated with antithyroid drugs. Clinica Chimica Acta 304 (2001) 39
16. Iitaka M., Miura S., Yamanaka K., Kawasaki S., Kitahama S., Kawakami Y., et al. Increased serum vascular endothelial growth factor levels and intrathyroidal vascular area in patients with Graves' disease and Hashimoto's thyroiditis. The Journal of Clinical Endocrinology and Metabolism 83 (1998) 3908